FDA To Require Clinical Studies for OTC Antibacterial Soaps, Washes

Washington Drug Letter
The FDA plans to mandate that manufacturers of antibacterial soaps and body washes submit clinical outcome study data that address safety and efficacy of their products, regulating them as they would other OTC medications.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00